# Stage39 Memory Write Readiness Report

Date: 2026-04-23

Conclusion:

- `ready_for_live: NEEDS_MORE_DATA`

Assessment basis:

- Requested source was `memory_write_shadow_log` or equivalent.
- In the current local database, no dedicated `memory_write_shadow_log` table exists.
- Equivalent dataset used for this check:
  - `episodic_memories`
  - filtered by `source_lane = 'inferred_extraction'`

Observed local snapshot:

- Local database queried on 2026-04-23.
- 157 inferred-shadow rows exist in the last 14 days.
- All 157 rows were created between `2026-04-20 09:58:02` and `2026-04-20 16:59:15`.
- Distinct users covered: 51.
- Average confidence: `0.9293`.
- `confidence` / `evidence_token` / `decay_policy` missing count: `0 / 0 / 0`.

Shadow divergence proxy:

- `revoked_at IS NOT NULL` in 14-day window: 16 rows.
- Proxy divergence rate: `16 / 157 = 10.19%`.
- `retracted_at IS NOT NULL`: 0 rows.
- `correction_count > 0`: 0 rows.

False-positive proxy:

- Because there is no dedicated reviewer outcome table in this local snapshot, false-positive rate was approximated with revocations.
- Proxy false-positive rate: `10.19%`.
- This is directionally useful, but not sufficient for a live-cut decision.

PII leakage proxy:

- `summary` email-like pattern hits: 0.
- `summary` 11-digit phone-like pattern hits: 0.
- `mentioned_entity_hash IS NOT NULL AND mentioned_entity_owner_user_id IS NULL`: 0.

Blocking findings:

1. Rule Y asked for a 14-day gray-window observation, but the available local data spans only one active day: `2026-04-20`.
2. `evidence_score` median is `0`, which means the local shadow sample is not yet showing a healthy evidence-quality distribution.
3. No dedicated shadow-review table was available locally, so divergence and false-positive are only proxy metrics, not adjudicated metrics.

Recommendation for Stage 40:

1. Keep Memory write on shadow.
2. Add or surface a dedicated shadow review log if one exists outside this local snapshot.
3. Re-run the readiness check only after a true 14-day window is available.
4. Require both:
   - adjudicated divergence rate under threshold
   - evidence-quality metrics above current baseline
